Diametric Capital, LP Aldeyra Therapeutics, Inc. Transaction History

Diametric Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$5.77 - $9.93 $130,257 - $224,169	22,575 New	22,575 $224,000
Q2 2021 Aug 16, 2021	SELL	$10.44 - $14.85 $108,315 - $154,068	-10,375 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $67,748 - $149,607	10,375 New	10,375 $123,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $278M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.